Parthenogenetic activation of mouse oocytes by strontium chloride: a search for the best conditions.
Strontium has been successfully used to induce activation of mouse oocytes in nuclear transfer and other experiments, but the optimum treatment conditions have not been studied systematically. When cumulus-free oocytes were treated with 10mM SrCl(2) for 0.5-5h, activation rates (88.4+/-4.1 to 91.2+/-2.7%) did not differ (mean+/-S.E.; P>0.2), but rate of blastulation (57.3+/-3.5%) and cell number per blastocyst (45.0+/-2.4) were the highest after treatment for 2.5h. When treated with 1-20mM SrCl(2) for 2.5h, the activation rate and cell number per blastocyst were higher (P<0.02) after 10mM SrCl(2) treatment than other treatments. The best activation and development were obtained with Ca(2+)-free Sr(2+) medium, but the activation rate was low (37.7+/-1.6%) in Ca(2+)-containing medium. Activation rates were the same, regardless of the presence or absence of cytochalasin B (CB) in the activating medium, but the blastulation rate was higher (P<0.001) in the presence of CB. Only 70% of the cumulus-enclosed oocytes were activated and 10% blastulated after a 10 min exposure to 1.6mM SrCl(2), and many lysed, with increased intensity of Sr(2+) treatment. The presence of CB in SrCl(2) medium markedly reduced lysis of cumulus-enclosed oocytes. Media M16 and CZB did not differ when used as activating media. Only 10.5% of the oocytes collected 13 h post hCG were activated by Sr(2+) treatment alone, with 34% blastulating, but rates of activation and blastulation increased (P<0.001) to 94 and 60%, respectively, when they were further treated with 6-dimethylaminopurine (6-DMAP). The total and ICM cell numbers were less (P<0.001) in parthenotes than in the in vivo fertilized embryos. In conclusion, the concentration and duration of SrCl(2) treatment and the presence or absence of CB in activating medium and cumulus cells had marked effects on mouse oocyte activation and development. To obtain the best activation and development, cumulus-free oocytes collected 18 h post hCG should be treated for 2.5h with 10mM SrCl(2) in Ca(2+)-free medium supplemented with 5 microg/mL of CB.
Ma
Suo-Feng
SF
Laboratory for Animal Reproduction and Embryology, College of Animal Science and Veterinary Medicine, Shandong Agricultural University, Tai-an City, Shandong Province 271018, PR China.
Liu
Xin-Yong
XY
Miao
De-Qiang
DQ
Han
Zheng-Bin
ZB
Zhang
Xia
X
Miao
Yi-Liang
YL
Yanagimachi
Ryuzo
R
Tan
Jing-He
JH
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000818:Animals; D001755:Blastocyst / Q000166:cytology; D002118:Calcium / Q000494:pharmacology; D002452:Cell Count; D003470:Culture Media; D003571:Cytochalasin B / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D046149:Embryo Culture Techniques; D005260:Female; D047908:Intracellular Signaling Peptides and Proteins / Q000494:pharmacology; D008274:Magnesium / Q000494:pharmacology; D051379:Mice; D009865:Oocytes / Q000187:drug effects / Q000502:physiology*; D010312:Parthenogenesis / Q000187:drug effects*; D013324:Strontium / Q000494:pharmacology*
D003470:Culture Media; D047908:Intracellular Signaling Peptides and Proteins; C015482:protein kinase modulator; D003571:Cytochalasin B; C001020:N(6),N(6)-dimethyladenine; C025700:strontium chloride; D008274:Magnesium; D000225:Adenine; D002118:Calcium; D013324:Strontium